CryoPort 

€6.95
22
+€0.25+3.73% 今天

統計

當日最高
6.6
當日最低
6.6
52週高點
9.5
52週低點
4.2
成交量
-
平均成交量
-
市值
347.98M
本益比
-
股息殖利率
-
股息
-

即將到來

財報

30Apr預期
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
下一步
-0.42
0.4
1.23
2.05
預期EPS
-0.221429
實際EPS
不適用

財務

-53.92%利潤率
未盈利
2019
2020
2021
2022
2023
2024
433.37M營收
-233.66M淨利

分析師評級

$10.24平均目標價
最高預估為 11.38。
來自過去6個月內的 3 則評分。這不是投資建議。
買入
100%
持有
0%
賣出
0%

其他人也在關注

此清單是根據在 Stock Events 上追蹤 CKX.F 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company's Life Sciences Services segment provides temperature-controlled logistics and cryogenic biostorage within the life science industry. Its Life Sciences Products segment offers cryogenic freezers, cryogenic dewars, and accessories within the life science industry through direct sales or a distribution network. The company's products include Cryoport Express Shippers; Cryoport ELITE Shippers; Cryoport Express Cryogenic HV3 Shipping System; Smartpak II Condition Monitoring System and Tec4Med; and Cryoport accessories. It also provides Cryoport BioStorage/Bioservices, such as CRYOGENE, a biostorage solution for the provision of pre-clinical temperature-controlled biological materials management services; and Cryoport Systems Bioservices, including controlled temperature storage, kitting, labelling, fulfillment, sample management, drug return, and Qualified Person drug product release. In addition, the company offers IntegriCell services that comprise apheresis/leukapheresis collection, cryoshuttle transportation, cryo-process optimization, and cryopreservation services; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; CRYOPDP, a temperature-controlled logistics solution; MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; and Vario cryogenic system, a cryogenic freezer system. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. The company was founded in 1999 and is based in Brentwood, Tennessee.
Show more...
執行長
Mr. Jerrell W. Shelton
員工
1090
國家
US
ISIN
US2290503075
WKN
000A14THD

上市

0 Comments

分享你的想法

FAQ

CryoPort 今天的股價是多少?
CKX.F 目前價格為 €6.95 EUR,過去 24 小時上漲了 +3.73%。在圖表上更密切關注 CryoPort 股價表現。
CryoPort 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,CryoPort 的股票以代號 CKX.F 進行交易。
CryoPort 的股價在上漲嗎?
CKX.F 股票較上週上漲 +1.46%,本月下跌 -0.71%,過去一年 CryoPort 上漲 +16.81%。
CryoPort 的市值是多少?
今天 CryoPort 的市值為 347.98M
CryoPort 下一次財報日期是什麼時候?
CryoPort 將於 April 30, 2026 公布下一次財報。
CryoPort 上一季度的財報如何?
CKX.F 上一季度的財報為每股 -0.23 EUR,預估為 -0.18 EUR,帶來 -28.51% 的驚喜。下一季度的預估財報為每股 不適用 EUR。
CryoPort 去年的營收是多少?
CryoPort 去年的營收為 433.37MEUR。
CryoPort 去年的淨利是多少?
CKX.F 去年的淨收益為 -233.66MEUR。
CryoPort 有多少名員工?
截至 April 01, 2026,公司共有 1,090 名員工。
CryoPort 位於哪個產業?
CryoPort從事於Industrials產業。
CryoPort 何時完成拆股?
CryoPort 最近沒有進行任何拆股。
CryoPort 的總部在哪裡?
CryoPort 的總部位於 US 的 Brentwood。